Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Carlisle Cathedral, University of Cumbria secure grant to explore science and faith connections in local farming landscapes - Lutheran Alliance for Faith, Science and Technology